Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
作者信息
Gopal Ajay K, Kahl Brad S, Flowers Christopher R, Martin Peter, Ansell Stephen M, Abella-Dominicis Esteban, Koh Brian, Ye Wei, Barr Paul M, Salles Gilles A, Friedberg Jonathan W
机构信息
Division of Medical Oncology, Department of Medicine, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, and Seattle Cancer Care Alliance, Seattle, WA.
Oncology Division, Department of Medicine, University of Wisconsin-Madison, Madison, WI.
出版信息
Blood. 2017 Jun 1;129(22):3037-3039. doi: 10.1182/blood-2016-12-757740. Epub 2017 Mar 21.
PMID:28325864
Abstract
摘要
Zotero 插件